METHOTREXATE IN RHEUMATOID-ARTHRITIS - A LIMITED SAMPLING STRATEGY FOR ESTIMATION OF THE AREA UNDER THE PLASMA-CONCENTRATION VERSUS TIME CURVE

被引:17
作者
EKSBORG, S
ALBERTIONI, F
BECK, O
PETERSON, C
SEIDEMAN, P
机构
[1] KAROLINSKA HOSP,DEPT CLIN PHARMACOL,STOCKHOLM,SWEDEN
[2] KAROLINSKA INST,DANDERYD HOSP,DEPT INTERNAL MED,DIV RHEUMATOL,STOCKHOLM,SWEDEN
关键词
METHOTREXATE; RHEUMATOID ARTHRITIS; PHARMACOKINETICS; THERAPEUTIC DRUG MONITORING; STEPWISE LINEAR REGRESSION;
D O I
10.1097/00007691-199412000-00005
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
A limited sampling strategy for determination of the area under the plasma concentration versus time curve (AUG) of methotrexate (MTX) in patients with rheumatoid arthritis (RA), treated with weekly oral doses, has been validated. Stepwise linear regression analysis was used for optimal inclusion of data points in mathematical models to estimate AUC. A new plot for evaluation of the accuracy and precision of the estimated AUC values was introduced in the present study. By plotting the ratio of determined/estimated AUC values versus estimated AUC values, the influence of number of sampling points on the precision and accuracy of estimated AUC values was easily validated. Our results show that AUC values of MTX in RA patients can be estimated from a single plasma sample at 3 h or preferably, due to increased precision, by additional samplings at 5 and 1 h. A further increase of the number of sampling points increased the precision of the AUC estimates only to a minor extent. The accuracy of the estimated AUC values was independent of the number of sampling points. A limited sampling procedure can now be used for further studies on the relationship between MTX levels and its effects.
引用
收藏
页码:560 / 563
页数:4
相关论文
共 24 条
[1]   TRACE ANALYSIS OF METHOTREXATE AND 7-HYDROXYMETHOTREXATE IN HUMAN PLASMA AND URINE BY A NOVEL HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD [J].
BECK, O ;
SEIDEMAN, P ;
WENNBERG, M ;
PETERSON, C .
THERAPEUTIC DRUG MONITORING, 1991, 13 (06) :528-532
[2]   DOSAGE PREDICTIONS IN HIGH-DOSE METHOTREXATE INFUSIONS .2. BAYESIAN-ESTIMATION OF METHOTREXATE CLEARANCE [J].
BRUNO, R ;
ILIADIS, A ;
FAVRE, R ;
LENA, N ;
IMBERT, AM ;
CANO, JP .
CANCER DRUG DELIVERY, 1985, 2 (04) :277-283
[3]  
BUCHBINDER R, 1993, J RHEUMATOL, V20, P639
[4]   DOSAGE PREDICTIONS IN HIGH-DOSE METHOTREXATE INFUSIONS .1. EVALUATION OF THE CLASSIC TEST-DOSE PROTOCOL [J].
CANO, JP ;
BRUNO, R ;
LENA, N ;
FAVRE, R ;
ILIADIS, A ;
IMBERT, AM .
CANCER DRUG DELIVERY, 1985, 2 (04) :271-276
[5]  
EKSBORG S, 1981, CLIN CHEM, V27, P1311
[6]   ASPIRIN, HYDROXYCHLOROQUINE, AND HEPATIC ENZYME ABNORMALITIES WITH METHOTREXATE IN RHEUMATOID-ARTHRITIS [J].
FRIES, JF ;
SINGH, G ;
LENERT, L ;
FURST, DE .
ARTHRITIS AND RHEUMATISM, 1990, 33 (11) :1611-1619
[7]   EFFECT OF ASPIRIN AND SULINDAC ON METHOTREXATE CLEARANCE [J].
FURST, DE ;
HERMAN, RA ;
KOEHNKE, R ;
ERICKSEN, N ;
HASH, L ;
RIGGS, CE ;
PORRAS, A ;
VENGPEDERSEN, P .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1990, 79 (09) :782-786
[8]   METHOTREXATE IN RESISTANT JUVENILE RHEUMATOID-ARTHRITIS - RESULTS OF THE USA-USSR DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].
GIANNINI, EH ;
BREWER, EJ ;
KUZMINA, N ;
SHAIKOV, A ;
MAXIMOV, A ;
VORONTSOV, I ;
FINK, CW ;
NEWMAN, AJ ;
CASSIDY, JT ;
ZEMEL, LS .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (16) :1043-1049
[9]   MORBIDITY ASSOCIATED WITH LONG-TERM METHOTREXATE THERAPY IN JUVENILE RHEUMATOID-ARTHRITIS [J].
GRAHAM, LD ;
MYONES, BL ;
RIVASCHACON, RF ;
PACHMAN, LM .
JOURNAL OF PEDIATRICS, 1992, 120 (03) :468-473
[10]   BAYESIAN-ESTIMATION AND PREDICTION OF CLEARANCE IN HIGH-DOSE METHOTREXATE INFUSIONS [J].
ILIADIS, A ;
BACHIRRAHO, M ;
BRUNO, R ;
FAVRE, R .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1985, 13 (01) :101-115